Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Thermo Fisher Scientific Introduces Next Generation Ion Chromatography Suppressor

Published: Friday, May 10, 2013
Last Updated: Friday, May 10, 2013
Bookmark and Share
The Thermo Scientific™ Dionex™ ERS™ 500 Electrolytically Regenerated Suppressor replaces the Thermo Scientific™ Dionex™ SRS™ 300 Self Regenerating Suppressor.

The Dionex ERS 500 Suppressor minimizes dispersion to deliver higher resolution separations, especially when coupled with Thermo Scientific™ Dionex™ 4 µm based IC columns. The Dionex ERS 500 suppressor permits improved compatibility with a wider range of detection techniques including MS, ICP, ICP-MS etc. due to its improved backpressure resilience. Additionally, the Dionex ERS 500 suppressor precludes the need for periodic chemical regeneration, allowing for greater ease of use and reproducibility.

Eluent suppression technology allows for a wide variety of inorganic and organic analyses for ion chromatography applications such as environmental, high purity water, semiconductor, high purity chemicals, food and beverage, pharmaceutical and process monitoring. Suppression greatly enhances signal-to-noise ratio by decreasing the background conductivity of the eluent and associated noise while simultaneously increasing analyte conductivity.

The Dionex ERS 500 is an electrolytic suppressor with a new hardware design that allows the suppressor to be more pressure tolerant than previous generation suppressor devices.  The suppressor flow pathway has been redesigned to optimize band dispersion and improve the flow and sealing properties.

“We invented eluent suppression years ago to help make ion chromatography a mainstream technique,” said Chris Pohl, Thermo Fisher vice president, chromatography chemistry. “We’ve never stopped striving to improve the usefulness of the technique, and this new suppressor is an example of this relentless innovation.”

The Dionex ERS 500 suppressor is truly the next generation in suppression technology, significantly improving ruggedness without sacrificing performance or ease-of-use.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Scientific Screening Library Advances Drug Discovery Research at Temple University’s Moulder Center
20,000-molecule Maybridge collection will help identify compound candidates to treat a wide range of diseases.
Thursday, October 20, 2011
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos